TOSI, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 16.915
EU - Europa 10.444
AS - Asia 2.643
SA - Sud America 40
AF - Africa 27
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 14
Totale 30.098
Nazione #
US - Stati Uniti d'America 16.856
GB - Regno Unito 3.916
IT - Italia 2.948
SE - Svezia 1.170
CN - Cina 916
HK - Hong Kong 683
DE - Germania 639
TR - Turchia 520
UA - Ucraina 517
FI - Finlandia 324
FR - Francia 230
BG - Bulgaria 215
SG - Singapore 166
IN - India 92
BE - Belgio 67
IE - Irlanda 62
RO - Romania 58
RU - Federazione Russa 57
ID - Indonesia 45
KR - Corea 44
LT - Lituania 44
CA - Canada 40
NL - Olanda 39
ES - Italia 38
CH - Svizzera 36
IR - Iran 34
IL - Israele 29
VN - Vietnam 28
MY - Malesia 22
JP - Giappone 18
GR - Grecia 17
CZ - Repubblica Ceca 15
PL - Polonia 15
BD - Bangladesh 14
EU - Europa 14
BR - Brasile 13
PT - Portogallo 13
MX - Messico 12
AU - Australia 9
TW - Taiwan 9
CL - Cile 8
CO - Colombia 7
EG - Egitto 7
HU - Ungheria 7
SN - Senegal 7
AR - Argentina 6
BZ - Belize 5
IQ - Iraq 5
NZ - Nuova Zelanda 5
PK - Pakistan 5
ZA - Sudafrica 5
AT - Austria 4
DK - Danimarca 4
MA - Marocco 3
YE - Yemen 3
AN - Antille olandesi 2
BO - Bolivia 2
BY - Bielorussia 2
DZ - Algeria 2
EC - Ecuador 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NG - Nigeria 2
PE - Perù 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
GH - Ghana 1
HR - Croazia 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
MT - Malta 1
NO - Norvegia 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 30.098
Città #
Southend 3.452
Fairfield 2.220
Chandler 1.670
Woodbridge 1.618
Ashburn 1.264
Jacksonville 1.135
Houston 976
Seattle 944
Dearborn 875
Wilmington 863
Ann Arbor 776
Nyköping 761
Cambridge 747
Hong Kong 661
Modena 499
Beijing 347
Izmir 324
Princeton 235
Sofia 211
Eugene 200
San Diego 197
New York 158
Milan 144
Helsinki 135
Redwood City 121
Rome 104
Singapore 100
London 96
Bologna 93
Bremen 93
Falls Church 93
Des Moines 83
Fremont 83
Brussels 61
Shanghai 61
Parma 53
Dublin 48
Florence 47
Jakarta 42
Reggio Emilia 42
Hefei 41
Boardman 39
Como 39
Tulare 39
Napoli 37
Norwalk 37
Nanjing 36
Frankfurt am Main 29
Kunming 29
Naples 28
Bari 26
Catania 25
San Giuliano Milanese 25
Los Angeles 23
Padova 23
Palermo 22
Dong Ket 20
Hounslow 19
Turin 19
Mountain View 18
Guangzhou 17
Jinan 16
Kocaeli 16
Verona 16
Central 15
Genoa 15
Indiana 15
Kilburn 15
Phoenix 15
Washington 15
Prescot 14
Saint Petersburg 14
Perugia 13
Halifax 12
Istanbul 12
Rende 12
Chicago 11
Dongguan 11
Ferrara 11
Limerick 11
Sassuolo 11
Zhengzhou 11
Auburn Hills 10
Barcelona 10
Carmichael 10
Chiswick 10
Hangzhou 10
San Mateo 10
Bengaluru 9
Chennai 9
Giv‘atayim 9
Messina 9
Paris 9
Pescara 9
Reggio Nell'emilia 9
Wuhan 9
Brescia 8
Chieti 8
Chongqing 8
Lappeenranta 8
Totale 22.668
Nome #
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 358
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 317
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 278
Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates 277
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 258
Protein corona and nanoparticles: How can we investigate on? 243
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 241
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 237
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 235
Nanoparticle transport across the blood brain barrier 227
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 227
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 224
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 224
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 224
Advances and perspectives for Central Nervous System drug delivery: the interface between nanotechnology and neuroscience 220
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 220
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 218
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 217
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 214
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 214
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 213
Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles 209
Biocatalytic asymmetric synthesis of (S)- and (R)-Timolol 207
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts 207
Dotap/Udca vesicles: novel approach in oligonucleotide delivery 207
AFM phase imaging of soft-hydrated samples: A versatile tool to complete the chemical-physical study of liposomes 206
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 205
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 201
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 201
The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system 200
PLGA nanoparticles surface decorated with the sialic acid, N-acetylneuraminic acid 199
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 196
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 196
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots 193
Sistema di veicolazione e rilascio di farmaci antiparassitari e loro uso in campo medico 191
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 191
Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution 191
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 190
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 188
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 188
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 188
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 187
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences. 185
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 183
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 182
Apoferritin nanocage as drug reservoir: is it a reliable drug delivery system? 182
Colloidal systems for CNS drug delivery 180
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 180
NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences. 180
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 180
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 179
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 179
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier 179
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 179
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 178
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 176
Functionalization of liposomes: microscopical methods for preformulative screening 175
EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION 175
Nanoparticles as Blood–Brain Barrier Permeable CNS Targeted Drug Delivery Systems 174
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 173
Chemo-enzymatic synthesis of levodropropizine 173
Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier 173
Nuclear localization of cationic solid lipid nanoparticles containing Protamine as transfection promoter 170
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 170
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 169
Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain 168
Glycopeptide-decorated nanoparticles as drug carriers for CNS: effects of surface coverage and carbohydrate type 168
Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy 168
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 167
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 167
Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures 166
NANOPARTICELLE POLIMERICHE PER IL DIREZIONAMENTO CEREBRALE: DELIVERY DI ZINCO E STUDI PRELIMINARI IN VITRO SU CELLULE NEURONALI 166
Detection of PLGA-based nanoparticles at single cell level by Synchrotron Radiation FTIR Spectromicroscopy and correlation with X-Ray Fluorescence Microscopy 165
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 164
STUDIO TECNOLOGICO DI OTTIMIZZAZIONE DI SISTEMI NANOPARTICELLARI ALLESTITI IN EMULSIONE SEMPLICE 163
Polymeric nanoparticles for the drug delivery to the central nervous system 163
Brain-targeted polymeric nanoparticles: in vivo evidences after different routes of administration in rodents. 160
Ketorolac tromethamine liposomes: Encapsulation and release studies 159
Brain targeting with polymeric nanoparticles: which administration route should we take? 159
Atomic force microscopy and photon correlation spectroscopy: Two techniques for rapid characterization of liposomes 158
LIPOPLEXES PER LA VEICOLAZIONE ED IL DIREZIONAMENTO DI siRNA AL PEL: VALUTAZIONE DELL’EFFICIENZA DI TRATTAMENTO CON SISTEMI LIPIDICI STABILIZZATI 157
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 157
Emerging use of nanotechnology in the treatment of neurological disorders 156
Nanomedicine and neurodegenerative disorders: So close yet so far 155
Nanosistemi lipidici targettizzati per il direzionamento di siRNA con attività antineoplastica al linfoma primitivo delle cavità sierose (PEL) 154
Application of atomic force microscopy to characterize liposomes as drug and gene carriers 153
Nanomedicine: the future for advancing medicine and neuroscience 153
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 153
Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier. 151
Peptide-derivatized biodegradable nanoparticles able to cross the blood brain barrier 148
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 147
Sintesi Asimmetrica Biocatalitica di (S)-(–)-Timolo 147
The bridge between Nanotechnology and Neuroscience: Neuro-Nanomedicine 147
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 147
Nanoparticles and the BBB crossing: in vivo and in vitro upcomings 145
Intact collagen and atelocollagen sponges: Characterization and ESEM observation 145
Nanomedicine against Aβ aggregation by β–sheet breaker peptide delivery: In vitro evidence 145
Conjugated poly(D,L-lactide-co-glycolide) for the preparation of in vivo detectable nanoparticles 144
Oral delivery of insulin loaded into polymeric nanoparticles in rats. 143
Nanoparticles for brain delivery of drugs: in vivo experiments andmechanism of BBB crossing 140
Totale 18.749
Categoria #
all - tutte 119.761
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 119.761


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.510 360 377 162 396 755 858 1.071 715 917 242 411 246
2020/20215.468 750 238 420 501 461 353 459 655 255 834 313 229
2021/20224.031 178 482 379 242 154 210 213 222 483 320 642 506
2022/20234.655 577 548 362 472 544 622 125 411 528 74 190 202
2023/20243.511 165 197 221 285 793 356 401 418 109 107 169 290
2024/202573 73 0 0 0 0 0 0 0 0 0 0 0
Totale 30.486